AIMD
Price
$3.46
Change
-$0.05 (-1.42%)
Updated
Sep 26, 12:56 PM (EDT)
Capitalization
16.7M
XLO
Price
$0.76
Change
-$0.00 (-0.00%)
Updated
Sep 26, 01:17 PM (EDT)
Capitalization
39.35M
41 days until earnings call
Interact to see
Advertisement

AIMD vs XLO

Header iconAIMD vs XLO Comparison
Open Charts AIMD vs XLOBanner chart's image
AINOS
Price$3.46
Change-$0.05 (-1.42%)
Volume$200
Capitalization16.7M
Xilio Therapeutics
Price$0.76
Change-$0.00 (-0.00%)
Volume$100
Capitalization39.35M
AIMD vs XLO Comparison Chart in %
Loading...
AIMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIMD vs. XLO commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIMD is a Hold and XLO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (AIMD: $3.51 vs. XLO: $0.76)
Brand notoriety: AIMD and XLO are both not notable
AIMD represents the Medical/Nursing Services, while XLO is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIMD: 1% vs. XLO: 26%
Market capitalization -- AIMD: $16.7M vs. XLO: $39.35M
AIMD [@Medical/Nursing Services] is valued at $16.7M. XLO’s [@Biotechnology] market capitalization is $39.35M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIMD’s FA Score shows that 0 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • AIMD’s FA Score: 0 green, 5 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, XLO is a better buy in the long-term than AIMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIMD’s TA Score shows that 1 TA indicator(s) are bullish while XLO’s TA Score has 5 bullish TA indicator(s).

  • AIMD’s TA Score: 1 bullish, 6 bearish.
  • XLO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XLO is a better buy in the short-term than AIMD.

Price Growth

AIMD (@Medical/Nursing Services) experienced а 0.00% price change this week, while XLO (@Biotechnology) price change was -0.55% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.74%. For the same industry, the average monthly price growth was +3.22%, and the average quarterly price growth was +9.80%.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

XLO is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical/Nursing Services (-1.74% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XLO($39.3M) has a higher market cap than AIMD($16.7M). AIMD YTD gains are higher at: 53.947 vs. XLO (-20.503). AIMD has higher annual earnings (EBITDA): -10.14M vs. XLO (-55.02M). XLO has more cash in the bank: 122M vs. AIMD (1.22M). XLO has less debt than AIMD: XLO (7.57M) vs AIMD (11M). XLO has higher revenues than AIMD: XLO (15M) vs AIMD (111K).
AIMDXLOAIMD / XLO
Capitalization16.7M39.3M42%
EBITDA-10.14M-55.02M18%
Gain YTD53.947-20.503-263%
P/E RatioN/AN/A-
Revenue111K15M1%
Total Cash1.22M122M1%
Total Debt11M7.57M145%
FUNDAMENTALS RATINGS
AIMD: Fundamental Ratings
AIMD
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AIMDXLO
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AIMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVA6.010.49
+8.88%
Inventiva SA
HWKN171.543.01
+1.79%
Hawkins
FITB45.280.11
+0.24%
Fifth Third Bancorp
ENTA7.75-0.06
-0.77%
Enanta Pharmaceuticals
EFOI2.94-0.15
-4.85%
Energy Focus

AIMD and

Correlation & Price change

A.I.dvisor tells us that AIMD and POAI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AIMD and POAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIMD
1D Price
Change %
AIMD100%
+2.63%
POAI - AIMD
30%
Poorly correlated
-19.47%
MBOT - AIMD
29%
Poorly correlated
-1.79%
CODX - AIMD
29%
Poorly correlated
-9.28%
CRMD - AIMD
28%
Poorly correlated
-1.07%
XLO - AIMD
26%
Poorly correlated
-0.87%
More

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and CRMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-0.87%
CRMD - XLO
31%
Poorly correlated
-1.07%
AXON - XLO
31%
Poorly correlated
+2.02%
VKTX - XLO
30%
Poorly correlated
-5.78%
AVTX - XLO
27%
Poorly correlated
-0.43%
CBIO - XLO
26%
Poorly correlated
-4.39%
More